In the News

Recent Articles

CDC Reveals Best Time to Get Flu Vaccine

International Flu Activity is on the Rise

American Academy of Pediatrics Flu Vaccine Recommendations

Voluntary Recall of Activase® 100 mg

ACIP Recommendations for the Use of Influenza Vaccines During the 2017-18 Season

NuFACTOR® Announces 2017 Annual Eric Dostie Memorial College Scholarship Recipients

Order Your FFF 2017-18 Flu Resource Materials Today!

Inadequate Rabies Treatment Consequences & Rh Blood Incompatibility During Pregnancy

Australia Experiencing Worst Flu Season Yet

Updated GamaSTAN® S/D Indications & Hepatitis A Outbreaks

CDC Released Flu Activity Report for 2016-17 Season

Rabies Mimics Flu & Rh-Negative Patient Profile

Prevent and Protect with HyperRAB® S/D & HyperRHO® S/D

General Best Practice Guidelines for Immunization to Replace General Recommendations on Immunization

New Study Shows Proactive Doctors Can Dramatically Increase Flu Vaccination Rates

WHO Strain Recommendations for 2017-18 Flu Vaccine

Flu Spreads Rapidly Across the United States

New Research Links Winter Cold Spell to Influenza Outbreaks

BIVIGAM® Announcement from Kedrion Biopharma

Anticipated 2017-2018 Flu Season Product Lineup

CUBICIN® Now Available thru VIPc

Beat the Flu During National Influenza Vaccination Week

Come Sea Our VIPc Demo at ASHP in Booth 513!

FluLaval® Quadrivalent Approved for Infants 6 months and Older

How Effective is the Flu Vaccine?

Get the Facts: What You Should Know About the Flu Vaccine

Community Immunity

Back to School - Flu Vaccine

Voluntary Recall of Helixate® FS - Additional Lots

Voluntary Recall of Kogenate® FS - Additional Lots

Voluntary Recall of Helixate® FS 2000 IU

Voluntary Recall of Kogenate® FS 2000 IU with Vial Adapter

Seqirus Flucelvax Quad PFS Approved for Persons 4 Years of Age and Older

Flu Season's Not Over Yet

Late Season Widespread Flu Activity On the Rise

2015-16 Seasonal Flu Vaccine Highly Effective

WHO Recommends One Strain Change for 2016-17 Flu Vaccine

Post Super Bowl Flu Blues
2015-16 Influenza Vaccines Available for Immediate Delivery

CDC Reports a Widespread Activity of Severe Influenza Illness

Cubicin® Now Available at FFF Enterprises

Miacalcin® Now Available at FFF Enterprises

Bio Products Laboratory (BPL) Enrolls First Subject in a Phase III Clinical Trial to Evaluate a New Subcutaneous Immunoglobulin Product for Patients with Primary Immunodeficiency

Octapharma USA: FDA Approves WILATE® License Supplement – Perioperative Management of Bleeding in Patients with von Willebrand Disease

VRBPAC Agrees with WHO Recommends Two Strain Change for 2015-16 Flu Vaccine

Flublok® Influenza Vaccine Now Approved for Adults Ages 18 and Older

FFF Enterprises Selects TraceLink to Meet DSCSA Regulations and Reinforce Ongoing Commitment to Patient Safety

MEPS Real-Time Announces Fiscal Year Milestones and Intelliguard RFID Solutions Achievements; Strengthens Corporate Structure for Future Growth

FFF Enterprises Supports The Neuropathy Association

UHC Awards Distributor Contract for Specialty Pharmacy Program to FFF Enterprises

U.S. Biologics Distributor Markets RFID Solution to Its Customers

Touting the Life-Giving Properties of Albumin

FDA Safety Communication: Boxed Warning on increased mortality and severe renal injury, and additional warning on risk of bleeding, for use of hydroxyethyl starch solutions in some settings

FFF Enterprises Announces 2013-2014 MyFluVaccine Ordering Is Now Underway

FFF Supports National Influenza Vaccination Week – December 2 through 8, 2012

Do No Harm – Why Healthcare Workers Need Flu Vaccines

Think it’s “Just” the Flu? Think Again

Study Emphasizes the Risks of Improper Vaccine Handling and Storage

Cangene Voluntarily Recalls HepaGam B Product Lots

Top-Line Results for Phase III Study of HyQ in PIDD Patients

An Update on Specialty Tier Legislation

New Medicare IVIG Access Bills Introduced

The Value of Vaccines

Influenza: The Domino Effect

FDA Approves New Software for Plasma Collection

Better by Design: New Coagulation Products on the Horizon

FDA Approves Shingles Vaccine for Ages 50-59

Grifols Wins Approval to Buy Talecris

Counteracting the Anti-Vaccine Movement: Promoting an Ounce of Prevention

Swine Flu Produces Protective Antibodies Against Other Flu Strains

The Role of Hyperimmune Globulins

Prenatal Flu Vaccine May Prevent Flu in Infants

HHS Seeks Comments on Creation of National Biovigilance Program

Plasma Therapies: Where Are We Now?

Immunoglobulin Similar to Plasma Exchange in Myasthenia Gravis

Preventable Harm: Medication Misuse

Shoring Up Supply Chain Security

Maintaining Supply Chain Safety - A Timely Message from FFF Enterprises

Making Safety a Priority

Safety First!

Is Your Medicine Safe?

Staying On the Forefront of the Biopharmaceutical Distribution Business

Five Important Reasons to Immunize Your Child

Support National Infant Immunization Week, April 26-May 2, 2009 — A Timely Message from FFF

Securing the Supply Chain (.pdf), Inside Healthcare, September 2008

Flu Vaccine Efficacy Myth Dispelled